The prognostic significance of ERCC1, BRCA1, XRCC1, and βIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2000 • 15,583 citations

Microtubules as a target for anticancer drugs

2004 • 4,193 citations

DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy

2006 • 1,691 citations

DNA repair pathways as targets for cancer therapy

2008 • 1,566 citations

A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer

1994 • 1,244 citations

A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer

1994 • 1,100 citations

Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin

2005 • 749 citations

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

2002 • 667 citations

Preoperative Chemotherapy Followed by Surgery Compared With Primary Surgery in Resectable Stage I (Except T1N0), II, and IIIa Non–Small-Cell Lung Cancer

2002 • 568 citations

Taxanes, microtubules and chemoresistant breast cancer

2007 • 517 citations

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

2007 • 452 citations

Mediastinal Lymph Node Clearance After Docetaxel-Cisplatin Neoadjuvant Chemotherapy Is Prognostic of Survival in Patients With Stage IIIA pN2 Non–Small-Cell Lung Cancer: A Multicenter Phase II Trial

2003 • 432 citations

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

2004 • 305 citations

Class III β-tubulin expression in tumor cells predicts response and outcome in patients with non–small cell lung cancer receiving paclitaxel

2005 • 214 citations

Expression of Class III β-Tubulin Is Predictive of Patient Outcome in Patients with Non–Small Cell Lung Cancer Receiving Vinorelbine-Based Chemotherapy

2005 • 193 citations

Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer

2003 • 193 citations

A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209)

2003 • 189 citations

Gene Expression as a Predictive Marker of Outcome in Stage IIB-IIIA-IIIB Non-Small Cell Lung Cancer After Induction Gemcitabine-Based Chemotherapy Followed By Resectional Surgery

2004 • 128 citations

ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

2008 • 104 citations

ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapy

2005 • 88 citations

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer

2007 • 80 citations

Predicting the outcome of chemotherapy for lung cancer

2006 • 74 citations

Current Treatment Paradigms for Locally Advanced Non-small Cell Lung Cancer

2007 • 46 citations

Platinum Resistance Related to a Functional NER Pathway

2007 • 37 citations

The place of excision repair cross complementation 1 (ERCC1) in surgically treated non-small cell lung cancer☆

2008 • 13 citations

Paclitaxel/Platinum-based Perioperative Chemotherapy and Surgery in Stage IIIA Non-small Cell Lung Cancer

2005 • 6 citations

Surgical Strategies and Outcomes after Induction Therapy for Non-Small Cell Lung Cancer

2005 • 5 citations

Role of Induction Chemotherapy in Resectable N2 Non-small Cell Lung Cancer

2007 • 3 citations

The expanding role of systemic treatment in non-small cell lung cancer neo-adjuvant therapy

2006 • 2 citations